References
- Bacopoulos N. G. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid. Biochem. Pharmacol. 1982; 31: 3085–3091
- Borochov H., Shinitzky M. Vertical displacement of membrane proteins mediated by changes in microviscosity. Proc. Natl. Acad. Sci. USA 1976; 73: 4526–4530
- Bruinink A. Binding sites for neuroleptics and beta-adrenergic blocking agents in rat brain: Pre- and postnatal development and diurnal rhythms. Dissertation. University of Zürich. 1983
- Bruinink A., Lichtensteiger W., Schlumpf M. Pre- and postnatal ontogeny and characterization of dopaminergic D2 serotonergic S2 and spirodecanone binding sites in rat forebrain. J. Neurochem. 1983; 40: 1227–1236
- Bruinink A., Lichtensteiger W. β-Adrenergic binding sites in fetal rat brain. J. Neurochem. 1984; 43, in press
- Dax E. M., Partilla J. S. Adrenergic ligand liposolubility in membranes. Direct assesment in a beta-adrenergic binding system. Mol. Pharmacol. 1982; 22: 5–7
- Heikkila R. E. Ascorbate-induced lipid peroxidation and the binding of (3H)dihydroalprenolol. Eur. J. Pharmacol. 1983; 93: 79–85
- Heikkila R. E., Cabbat F. S., Manzino L. Inhibitory effects of ascorbic acid on the binding of (3H)dopamine antagonists to neostriatal membrane preparations: Relationship to lipid peroxidation. J. Neurochem. 1982; 38: 1000–1006
- Heron D. S., Israeli M., Hershkowitz M., Samuel D., Shinitzky M. Lipid-induced modulation of opiate receptors in mouse brain membranes. Eur. J. Pharmacol. 1981; 72: 361–364
- Hirata F., Strittmatter W. J., Axelrod J. Phospholipid methylation, membrane fluidity and coupling of the β-adrenergic receptor. Catecholamines: Basic and Clinical Frontiers. Pergamon press, New York 1979; 501
- Leff S., Sibley D. R., Hamblin M., Creese I. Ascorbic acid enables reversible dopamine receptor 3H-agonist binding. Life Sci. 1981; 29: 2081–2090
- Lowry O. H., Rosebrough N. J., Far A. L., Randall R. J. Protein measurement with the Folin reagent. J. Biol. Chem. 1951; 193: 265–275
- Muakkassah-Kelly S. F., Andresen J. W., Shih J. C., Hochstein P. Dual effects of ascorbate on serotonin and spiperone binding in rat cortical membranes. J. Neurochem. 1983; 41: 1429–1439
- Norman J. A., Drummond A. H. Inhibition of calcium-dependent regulator-stimulated phosphodiesterase activity by neuroleptic drugs is unrelated to their clinical efficacy. Mol. Pharmacol. 1979; 16: 1089–1094
- Sharma O. P., Krishna Murti C. R. Ascorbic acid a naturally occuring mediator of lipid peroxide formation in rat brain. J. Neurochem. 1976; 27: 299–301
- Triggs W. J., Willmore L. J. In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection. J. Neurochem. 1984; 42: 976–980